|
|
|
|
|
|
In this new Transfusion Science Webinar, Dr. Jorge Monge Ruiz will describe various discrepant ABO results and offer strategies to handle them. He will then explore the characteristics of ABO compatibility in the context of blood transfusion and pregnancy as well as in hematopoietic stem cell and solid organ transplantation scenarios.
Can't make it? Register anyway for the recorded webinar.
|
|
|
| Jorge Monge Ruiz, MD Head of the Immunohematology Laboratory
Basque Center for Blood Transfusion and Human Tissues (Osakidetza), Galdakao, Spain. |
|
|
|
|
The Shape of ABO
Session 1: June 4, 2024, 8:00 AM PDT / 5:00 PM CEST
Session 2: June 6, 2024, 3:00 PM SGT / 09:00 AM CEST
|
|
|
ABO blood typing is the cornerstone of pre-transfusion testing, which ensures the provision of safe and compatible blood components. This test is based on the detection of A and B antigens on red blood cells using anti-A and anti-B reagents (called forward typing) as well as the detection of anti-A and anti-B in plasma/serum with the use of reagent red blood cells of group A1 and B (called reverse typing).
Both tests, forward and reverse, should match to report an ABO blood type. Any discrepancies should be investigated and may be explained by cold antibodies, subgroups of A or B, lymphoma/leukemia, bone marrow transplant, or other conditions. Once discrepancies have been resolved, recommendations may be provided on the safest blood component for transfusion.
|
|
|
|
|
